Active ingredientIcatibantCat. No. P-I012-001CAS 130308-48-4Family · Pharmaceutical analytical standards
Icatibant
A synthetic bradykinin B2 receptor antagonist, a peptide of ten amino acids authorised first in Europe and then, in 2011, in the United States for acute attacks of hereditary angioedema. This family brings together the active ingredient and other impurities.
Did you know?Five of its ten amino acids are not among those that build proteins: this makes it resistant to the enzymes that rapidly break down bradykinin.
Go to the active ingredient →Active ingredientIcatibantCat. No. P-I012-001CAS 130308-48-4
Active ingredientIcatibant AcetateCat. No. P-I012-002CAS 138614-30-9
ImpurityIcatibant Impurity 1Cat. No. P-I012-003CAS 103733-65-9
ImpurityFmoc-L-Tic-OHCat. No. P-I012-004CAS 136030-33-6
ImpurityIcatibant Impurity 2Cat. No. P-I012-005
ImpurityIcatibant Impurity 3Cat. No. P-I012-006CAS 259882-53-6
ImpurityIcatibant Impurity 4Cat. No. P-I012-007
ImpurityIcatibant Impurity 5Cat. No. P-I012-008
ImpurityIcatibant Impurity 6Cat. No. P-I012-010
ImpurityIcatibant Impurity 7Cat. No. P-I012-011
ImpurityIcatibant Impurity 8 DihydrochlorideCat. No. P-I012-012
ImpurityIcatibant Impurity 9 TrifluoroacetateCat. No. P-I012-013No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.